PeproTech Inc.
Originally published online as doi:10.1189/jlb.0209087 on July 14, 2009

Published online before print July 14, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0209087v1
86/5/1097    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Boé, D. M.
Right arrow Articles by Moss, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boé, D. M.
Right arrow Articles by Moss, M.
(Journal of Leukocyte Biology. 2009;86:1097-1104.)
© 2009 Society for Leukocyte Biology

Alcohol abuse and pulmonary disease

Darren M. Boé1, R. William Vandivier, Ellen L. Burnham and Marc Moss

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, Colorado, USA

1. Correspondence: Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, 12700 E. 19th Ave., C272, Aurora, CO 80045, USA. E-mail: darren.boe{at}ucdenver.edu

ABSTRACT

ARDS is a severe form of lung injury characterized by increased permeability of the alveolar capillary membrane, diffuse alveolar damage, the accumulation of proteinaceous interstitial and intra-alveolar edema, and the presence of hyaline membranes. These pathological changes are accompanied by physiological alterations, including severe hypoxemia, an increase in pulmonary dead space, and decreased pulmonary compliance. Approximately 200,000 individuals develop ARDS in the United States each year [1 ], and nearly 50% of these patients have a history of alcohol abuse. We have identified alcohol abuse as an independent risk factor for the development of ARDS [2 3 4 5 ], and more recent studies have validated these findings in patients following lung resection and blood transfusion [2 , 3 ]. In ARDS survivors, alcohol abuse is also associated with an increased duration of mechanical ventilation and prolonged ICU length of stay [5 ]. Despite studies aimed at improving outcomes in patients with ARDS, the mortality remains high at >40% [6 ]. For those who abuse alcohol, the mortality is even higher, at 65% [4 ]. In this review, we will discuss the relationship between alcohol abuse and ARDS, the effects of alcohol abuse on pulmonary function, and future directions and potential therapeutic targets for patients at risk for ARDS as a result of alcohol abuse, which impairs immune function, decreases pulmonary antioxidant capacity, decreases alveolar epithelial cell function, alters activation of the renin angiotensin system, and impairs GM-CSF signaling. These pathways represent potential therapeutic targets for patients at risk for ARDS as a result of alcohol abuse.

Key Words: lung injury • oxidative stress